title: Chemotherapy of acute myeloid leukemia of 35- to 60-year-old patients.
authors.affiliation: Medical Academy of Dresden.
authors.forename: J
authors.initials: J
authors.lastname: Fleischer
authors.forename: U
authors.initials: U
authors.lastname: Reinhardt
authors.forename: H
authors.initials: H
authors.lastname: Wolf
authors.forename: W
authors.initials: W
authors.lastname: Helbig
authors.forename: G
authors.initials: G
authors.lastname: Anger
authors.forename: I
authors.initials: I
authors.lastname: Grau
authors.forename: G
authors.initials: G
authors.lastname: Schott
authors.forename: H
authors.initials: H
authors.lastname: Konrad
authors.forename: C
authors.initials: C
authors.lastname: Klinkenstein
authors.forename: J
authors.initials: J
authors.lastname: Steglich
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007947:Leukemia, Megakaryoblastic, Acute / Q000175:diagnosis; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000175:diagnosis / Q000209:etiology